JTJapan Times·3hHealth
score-0.60
Lower House Acts to Protect Cancer and Intractable Disease Patients as 25% OTC-Like Drug Cost Reform Set for 2027
Original
Lower House approves bills to raise out-of-pocket costs for OTC-like drugs
“Headline emphasizes cost increases for patients with word 'raise' and 'out-of-pocket,' creating concern about affordability despite carve-outs for serious conditions.”